中國生態旅遊(01371.HK)2021年虧損收窄至2.56億港元
格隆匯3月31日丨中國生態旅遊(01371.HK)公佈,截至2021年12月31日止年度,公司營業額1.17億港元,同比減少1%;公司擁有人應占虧損2.56億港元,上年同期虧損5.74億港元;每股虧損11.73港仙。
2021年,受全球新冠疫情蔓延影響,本集團海外市場開拓受到一定限制,但集團仍持續開展海外彩票業務的技術準備工作。集團進一步為迦納國家彩票局建設運營監管平台,後續將增加更多適合於當地市場、互動性更強的彩票新產品。同時,為菲律賓彩票市場開發的新遊戲已基本完成,預計2022年與菲律賓國家彩票機構(PCSO)合作開展的手持終端彩票業務將實現上線銷售,並有望在緬甸開展手機互聯網銷售彩票業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.